The development of the current generation of antipsychotics has depended on
animal, biochemical and pharmacological models of the action of drugs disc
overed serentipidously, They have focused on the dopamine hypothesis of sch
izophrenia. More recent studies of the structural abnormalities in schizoph
renia, coupled with an understanding of the genetics and developmental biol
ogy of brain development, point to a new generation of novel medicines and
therapies for patients with this disorder. (C) 2000 Published by Elsevier S
cience B.V. All rights reserved.